Advertisement

Epidemiology of Thyroid Disorders

  • Mark P. J. VanderpumpEmail author
Chapter

Abstract

The manifestations of benign thyroid diseases vary considerably and are determined principally by the in the dietary availability of iodine which is an essential component of the thyroid hormones. The limitations of epidemiological studies of thyroid disorders should therefore be borne in mind when considering the purported frequency of thyroid diseases in different communities. Almost one-third of the world’s population live in areas of iodine deficiency despite major national and international efforts to increase iodine intake, but iodine deficiency is an emerging issue in industrialised countries, previously thought of as iodine-sufficient. In iodine-replete areas, most persons with thyroid disorders have autoimmune disease, ranging from primary atrophic hypothyroidism to Hashimoto’s thyroiditis to thyrotoxicosis caused by Graves’ disease. The prevalence of spontaneous hypothyroidism is between 1 and 2%, and it is more common in older women and ten times more common in women than in men. The prevalence of hyperthyroidism in women is between 0.5 and 2% and is ten times more common in women than in men. Epidemiological studies suggest that 1% of men and 5% of women have thyroid nodules detected clinically and that the frequency increases with age and in iodine-deficient populations. In iodine-replete areas, congenital hypothyroidism affects about one newborn in 3500–4000 births, and the value of screening for congenital hypothyroidism in heel-prick blood specimens is unquestioned. Controversy exists as to whether healthy adults from screening for thyroid disease as the prevalence of unsuspected overt thyroid disease is low, but a substantial proportion of subjects tested will have evidence of thyroid dysfunction, with approximately 10% with subclinical hypothyroidism and 1% with subclinical hyperthyroidism. No appropriately powered prospective, randomised, controlled, double-blinded interventional trial for subclinical thyroid disease exists.

Keywords

Epidemiology Iodine deficiency Hypothyroidism Autoimmunity Hyperthyroidism Goitre Thyroid nodules Screening Prevalence Incidence 

References

  1. 1.
    Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39–51.CrossRefGoogle Scholar
  2. 2.
    Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3:286–95.CrossRefGoogle Scholar
  3. 3.
    Vanderpump MPJ. Thyroid and iodine nutritional status: a UK perspective. Clin Med (Lond). 2014;14:s7–s11.CrossRefGoogle Scholar
  4. 4.
    Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526–34.CrossRefGoogle Scholar
  5. 5.
    Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489–99.CrossRefGoogle Scholar
  6. 6.
    Laurberg P, Bulow Pedersen I, Knudsen N, et al. Environmental iodine intake affects the type of non-malignant thyroid disease. Thyroid. 2001;11:457–69.CrossRefGoogle Scholar
  7. 7.
    Teng W, Shan Z, Teng X, et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med. 2006;354:2783–93.CrossRefGoogle Scholar
  8. 8.
    McGrogan A, Seaman HE, Wright JW, et al. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin Endocrinol. 2008;69:687–96.CrossRefGoogle Scholar
  9. 9.
    Zimmerman MB, Andersson M. Assessment of iodine nutrition in populations; past, present and future. Nutr Rev. 2012;70:553–70.CrossRefGoogle Scholar
  10. 10.
    WHO global database on iodine deficiency. Geneva: World Health Organisation. http://www.who.int/vmnis/database/iodine/iodine_data_status_summary/en/index.html. Accessed 6 Nov 2016.
  11. 11.
    Zimmermann MB, Gizak M, Abbott K, et al. Iodine deficiency in pregnant women in Europe. Lancet Diabetes Endocrinol. 2015;3:672–4.CrossRefGoogle Scholar
  12. 12.
    Bougma K, Aboud FE, Harding KB, et al. Iodine and mental development of children 5 years old and under: a systematic review and meta-analysis. Nutrients. 2013;5:1384–416.CrossRefGoogle Scholar
  13. 13.
    Vanderpump MP, Lazarus JH, Smyth PP, et al. Iodine status of UK schoolgirls: a cross-sectional survey. Lancet. 2011;377:2007–12.CrossRefGoogle Scholar
  14. 14.
    Bath SC, Steer CD, Golding J, et al. Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC) study. Lancet. 2013;381:331–7.CrossRefGoogle Scholar
  15. 15.
    Russ G, Leboulleux S, Leenhardt L, et al. Thyroid incidentalomas: epidemiology, risk stratification with ultrasound and workup. Eur Thyroid J. 2014;3:154–63.CrossRefGoogle Scholar
  16. 16.
    Wassner AJ, Brown RS. Congenital hypothyroidism: recent advances. Curr Opin Endocrinol Diabetes Obes. 2015;22:407–12.CrossRefGoogle Scholar
  17. 17.
    Biondi B, Cooper DC. Subclinical thyroid disease. Lancet. 2012;379:1142–54.CrossRefGoogle Scholar
  18. 18.
    Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005;90:5483–8.CrossRefGoogle Scholar
  19. 19.
    Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab. 2005;90:5489–96.CrossRefGoogle Scholar
  20. 20.
    Surks MI, Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab. 2010;95:496–502.CrossRefGoogle Scholar
  21. 21.
    Meyerovitch J, Rotman-Pikielny P, Sherf M, et al. Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch Intern Med. 2007;167:1533–8.CrossRefGoogle Scholar
  22. 22.
    Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol. 1995;43:55–69.CrossRefGoogle Scholar
  23. 23.
    Flynn RV, MacDonald TM, Morris AD, et al. The thyroid epidemiology, audit and research study; thyroid dysfunction in the general population. J Clin Endocrinol Metab. 2004;89:3879–84.CrossRefGoogle Scholar
  24. 24.
    Leese GP, Flynn RV, Jung RT, et al. Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology, Audit and Research Study (TEARS). Clin Endocrinol. 2008;68:311–6.Google Scholar
  25. 25.
    Schouten BJ, Brownlie BE, Frampton CM, et al. Subclinical thyrotoxicosis in an outpatient population—predictors of outcome. Clin Endocrinol. 2011;74:257–61.CrossRefGoogle Scholar
  26. 26.
    Vadiveloo T, Donnan PT, Cochrane L, Leese GP. The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab. 2011;96:59–61.CrossRefGoogle Scholar
  27. 27.
    De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:2543–65.CrossRefGoogle Scholar
  28. 28.
    Rugge JB, Bougatsos C, Chou R. Screening and treatment of thyroid dysfunction: an evidence review for the U.S. preventive services task force. Ann Intern Med. 2015;162:35–45.CrossRefGoogle Scholar
  29. 29.
    Rodondi N, den Elzen WPJ, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365–74.CrossRefGoogle Scholar
  30. 30.
    Cappola AR, Arnold AM, Wulczyn K, et al. Thyroid function in the euthyroid range and adverse outcomes in older adults. J Clin Endocrinol Metab. 2015;100:1088–96.CrossRefGoogle Scholar
  31. 31.
    Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2:215–28.CrossRefGoogle Scholar
  32. 32.
    Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172:799–809.CrossRefGoogle Scholar
  33. 33.
    Wirth CD, Blum MR, da Costa BR, et al. Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis. Ann Intern Med. 2014;161:189–99.CrossRefGoogle Scholar
  34. 34.
    Biondi B, Bartalena L, Cooper DS, et al. The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J. 2015;4:149–63.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.The Physicians’ ClinicLondonUK

Personalised recommendations